{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-25-008571","form_type":"8-K","ticker":"XLO","cik":"0001840233","company_name":"Xilio Therapeutics, Inc.","filed_at":"2025-06-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.064170+00:00","generated_at":"2026-05-19T11:11:10.799581+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Xilio stockholders elect Class I directors, approve 3x share increase and officer exculpation","bullets":["René Russo (32.5M), Sara Bonstein (32.4M), James Shannon (31.0M) elected Class I directors.","Share increase amendment approved: 38.8M for (95.1%), increasing authorized common from 200M to 600M shares; filed June 10.","Officer exculpation amendment approved: 32.3M for (99.3%); filed June 10.","Ernst & Young ratified as auditor for FY2025: 40.7M for (99.7%)."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-25-008571","json":"https://secwatch.observer/filing/0001558370-25-008571.json","markdown":"https://secwatch.observer/filing/0001558370-25-008571.md","text":"https://secwatch.observer/filing/0001558370-25-008571.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840233/000155837025008571/0001558370-25-008571-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840233/000155837025008571/xlo-20250610x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T11:11:10.799581+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}